Comparison
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 vs 16p13 11 Microduplication Syndrome C4304595
Clinical comparison between 3 Beta Hydroxysteroid Dehydrogenase Deficiency and 16p13 11 Microduplication Syndrome for differential diagnosis and treatment planning.
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
A rare genetic disorder affecting adrenal hormone production. It can cause ambiguous genitalia, salt-wasting crises, and hormonal imbalances. Treatment requires hormone replacement therapy and careful monitoring.
16p13 11 Microduplication Syndrome C4304595
A rare genetic condition from duplication of a segment on chromosome 16. Features may include developmental delays and learning differences. Management focuses on supportive care and early intervention.
6 comparison axes
Onset
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
0-null
16p13 11 Microduplication Syndrome C4304595
0-null
Onset patterns differ
Severity
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
severe
16p13 11 Microduplication Syndrome C4304595
moderate
Different severity levels
Chronic
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
Chronic
16p13 11 Microduplication Syndrome C4304595
Chronic
Differing course
Communicable
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
No
16p13 11 Microduplication Syndrome C4304595
No
Different transmission
Body System
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
endocrine
16p13 11 Microduplication Syndrome C4304595
congenital
Same/different system
Category
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
endocrine
16p13 11 Microduplication Syndrome C4304595
genetic
Different category
Bottom line
3-beta-hydroxysteroid-dehydrogenase-deficiency-C0342471 and 16p13-11-microduplication-syndrome-C4304595 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 | 16p13 11 Microduplication Syndrome C4304595 | Discriminating power |
|---|---|---|---|
| Genital development | Ambiguous genitalia may occur from disordered adrenal and gonadal steroid production. | Genital ambiguity is not an established feature in the supplied description. | High |
| Salt-wasting crisis | Acute salt-wasting crisis is a recognized possible presentation and requires urgent care. | Salt-wasting is not described for this chromosomal condition. | High |
| Development and learning | Developmental delay is not the defining feature in the supplied description. | Developmental delays and learning differences may be present. | Moderate |
When to favor each condition
Choose 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 when
Infant with ambiguous genitalia and suspected adrenal crisis
The endocrine description specifically includes these features and severe hormone imbalance.
High
Abnormal steroid profile suggesting impaired adrenal hormone production
This points toward an adrenal steroidogenic disorder rather than a chromosomal duplication.
Moderate
Need for lifelong hormone replacement planning
The supplied management is hormone replacement with careful monitoring, not primarily developmental support.
Moderate
Choose 16p13 11 Microduplication Syndrome C4304595 when
Child with developmental delay and learning differences
These are the features explicitly associated with the chromosomal duplication.
Moderate
Chromosomal microarray shows a 16p13.11 duplication
A confirmed duplication supports this genetic diagnosis over an adrenal enzyme deficiency.
High
No clinical evidence of adrenal hormone failure
Absence of salt-wasting or genital ambiguity makes the endocrine disorder less likely, but does not exclude all genetic conditions.
Low
How key tests differ
| Test | 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 | 16p13 11 Microduplication Syndrome C4304595 | Interpretation |
|---|---|---|---|
| Adrenal steroid evaluation | May show disordered adrenal steroid production; exact cutoffs are not supplied. | No characteristic adrenal steroid abnormality is established here. | Abnormal results suggest an endocrine disorder but require specialist confirmation. |
| Chromosomal microarray | Not expected to identify 16p13.11 duplication as the cause. | May detect duplication of the 16p13.11 segment. | A duplication finding supports the chromosomal condition; clinical correlation is required. |
| Electrolytes during illness | Salt-wasting may cause clinically important electrolyte disturbance. | No specific electrolyte pattern is established. | Abnormal electrolytes are a result, not a diagnosis, and need urgent clinician review. |
Prognosis comparison
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
- Outcome
- A severe chronic endocrine condition whose individual outcome is not quantified here.
- Factors
- Hormone replacement, crisis prevention, and specialist monitoring are described management factors.
16p13 11 Microduplication Syndrome C4304595
- Outcome
- A moderate chronic congenital condition with variable developmental impact; exact outcomes are not established.
- Factors
- Supportive care, early intervention, and individual learning needs may influence function.
Time frame: Both are described as chronic; no reliable survival or recovery timeline is supplied.
Prognosis should be interpreted by clinicians because source data are sparse.
Complications comparison
| Complication | Presentation |
|---|---|
| Adrenal crisis | Salt-wasting crisis is a described severe risk. Not described in the supplied source. Suspected crisis needs emergency care; exact frequency is not established. |
| Hormonal imbalance | Chronic imbalance may affect sexual development and require replacement therapy. No specific hormonal complication is established here. Management and monitoring should be individualized by specialists. |
| Learning and developmental needs | Not the main complication in the supplied description. Developmental delay and learning differences may require ongoing support. Needs vary; early intervention is the described approach. |
Patient education highlights
- HighDifferent conditions
These conditions have different causes: adrenal steroid production versus a chromosome 16 duplication.
- HighUrgent symptoms
For suspected salt-wasting or adrenal crisis, seek emergency care rather than waiting for routine review.
- MediumFollow-up
Endocrine replacement needs monitoring, while the chromosomal condition emphasizes developmental support and early intervention.